Published in Schweiz Med Wochenschr on December 11, 1976
A research standard for human serum immunoglobulins IgG, IgA and IgM. Bull World Health Organ (1970) 7.25
A simple epidemiological model for evaluating the malaria inoculation rate and the risk of infection in infants. Bull World Health Organ (1974) 3.93
An international reference preparation for human serum immunoglobulins G, A and M: content of immunoglobulins by weight. Bull World Health Organ (1972) 2.82
Epidemiological model of typhoid fever and its use in the planning and evaluation of antityphoid immunization and sanitation programmes. Bull World Health Organ (1971) 2.77
Dispersion studies of Culex pipiens fatigans tagged with 32P in the Kemmendine area of Rangoon, Burma. Bull World Health Organ (1967) 2.31
Indicators for the forecasting of malaria epidemics. Bull World Health Organ (1980) 2.15
The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia. Eur J Clin Pharmacol (1994) 2.04
Simple method for rough determination of the cost-benefit balance point of immunization programmes. Bull World Health Organ (1971) 1.79
Impact of control measures on malaria transmission and general mortality. Bull World Health Organ (1976) 1.72
Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. Eur J Biochem (1993) 1.57
Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 1. Results of in vivo and in vitro studies and of an ophthalmological survey. Bull World Health Organ (1982) 1.56
The transmission potential of monkeypox virus in human populations. Int J Epidemiol (1988) 1.50
The international standard for colistin. Bull World Health Organ (1973) 1.38
Rough determination of the cost-benefit balance point of sanitation programmes. Bull World Health Organ (1976) 1.37
The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care (1983) 1.32
Evaluation of Wuchereria bancrofti infection in Culex pipiens fatigans in Rangoon, Burma. Bull World Health Organ (1967) 1.17
Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid. Biochim Biophys Acta (1995) 1.16
Human monkeypox: secondary attack rates. Bull World Health Organ (1988) 1.15
Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations. Biochem J (1994) 1.15
Human monkeypox: confusion with chickenpox. Acta Trop (1988) 1.15
Prognosis of functional recovery 1 year after hip fracture: typical patient profiles through cluster analysis. J Gerontol A Biol Sci Med Sci (2000) 1.14
Statistical considerations in serological surveys of population with particular reference to malaria. J Trop Med Hyg (1974) 1.09
Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res (1989) 1.09
Human monkeypox: disease pattern, incidence and attack rates in a rural area of northern Zaire. Trop Geogr Med (1988) 1.06
Asymptomatic bacteriuria in diabetes mellitus. N Engl J Med (1967) 1.05
Incipient resistance of Plasmodium falciparum to chloroquine among a semi-immune population of the United Republic of Tanzania. 2. The impact of chloroquine used as a chemosuppressant on the immune status of the population. Bull World Health Organ (1982) 1.05
Clinico-epidemiological features of monkeypox patients with an animal or human source of infection. Bull World Health Organ (1988) 1.01
Low density lipoprotein causes general cellular activation with increased phosphatidylinositol turnover and lipoprotein catabolism. Proc Natl Acad Sci U S A (1988) 1.00
[Longitudinal sero-epidemiologic study of malaria in Tunisia]. Bull World Health Organ (1976) 0.98
Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects. Diabetes (1990) 0.96
Dynamics of acute bacterial diseases. Epidemiological models and their application in public health. Part II. Epidemiological models of acute bacterial diseases. Bull World Health Organ (1978) 0.95
Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia (1981) 0.95
Epidemiological models of poliomyelitis and measles and their application in the planning of immunization programmes. Bull World Health Organ (1982) 0.95
Characterization of a human high density lipoprotein-associated protein, NA1/NA2. Identity with SP-40,40, an inhibitor of complement-mediated cytolysis. Arterioscler Thromb (1991) 0.94
Stochastic model for interhuman spread of monkeypox. Am J Epidemiol (1987) 0.94
Protein heterogeneity of lipoprotein particles containing apolipoprotein A-I without apolipoprotein A-II and apolipoprotein A-I with apolipoprotein A-II isolated from human plasma. J Lipid Res (1988) 0.90
Serum immunoglobulin concentrations in epidemic meningococcal meningitis in Niger. Bull World Health Organ (1971) 0.86
Quantitative studies on the lipolytic response of human subcutaneous and omental adipose tissue to noradrenaline and theophylline. Acta Med Scand (1969) 0.86
Treatment of hyperlipoproteinemia (HLP) type II A with a new phenoxy-isobuturic acid derivative, procetofen. Int J Clin Pharmacol Biopharm (1979) 0.85
[Dyslipidemia in the diabetic patient. Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. Diabete Metab (1995) 0.85
Purification and analysis of synthetic, triple-helical "minicollagens" by reversed-phase high-performance liquid chromatography. Anal Biochem (1995) 0.85
Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia (1995) 0.83
Methods for the surveillance of endemic treponematoses and sero-immunological investigations of "disappearing" disease. Bull World Health Organ (1972) 0.83
Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. Biochim Biophys Acta (1989) 0.82
[Maximum gastric stimulation with the augmented histamine test in healthy children]. Helv Paediatr Acta (1969) 0.82
Effect of nicotinic acid on ACTH and noradrenaline stimulated lipolysis in the rabbit. II. In vitro studies including comparison with prostaglandin E1. Acta Physiol Scand (1970) 0.81
HDL lipids in close relatives of coronary heart disease patients. Environmental and genetic influences. Atherosclerosis (1979) 0.81
Liver glycerokinase deficiency in man with hyperglycerolaemia and hypertriglyceridaemia. Eur J Clin Invest (1984) 0.81
HDL particle associated proteins in plasma and cerebrospinal fluid: identification and partial sequencing. Appl Theor Electrophor (1988) 0.81
Distribution of apolipoprotein E between free and A-II complexed forms in very-low- and high-density lipoproteins: functional implications. Biochim Biophys Acta (1991) 0.81
An International Reference Preparation for human serum immunoglobulin E. Bull World Health Organ (1973) 0.81
Iron excess, early glucose intolerance and impaired insulin secretion in idiopathic haemochromatosis. Eur J Clin Invest (1973) 0.81
Metabolic effects of dietary fiber from dehulled soybeans in humans. Am J Clin Nutr (1983) 0.80
Immunofractionation of high density lipoprotein subclasses 2 and 3. Similarities and differences of fractions isolated from male and female populations. Atherosclerosis (1990) 0.80
[Apoprotein E (apo E) phenotype and serum lipids in diabetics]. Schweiz Med Wochenschr (1987) 0.79
Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms. Clin Chim Acta (1994) 0.78
Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI,AII. J Lipid Res (1994) 0.78
Apolipoprotein E polymorphism as a risk factor for vascular disease in diabetic patients. Diabetes Care (1995) 0.78
Fat mobilizing lipolysis and levels of cyclic AMP in human and dog adipose tissue. Acta Med Scand (1970) 0.78
The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 0.78
High density lipoprotein cholesterol in male relatives of patients with coronary heart disease. Atherosclerosis (1979) 0.78
Comparison of lipolysis in human subcutaneous and omental adipose tissue with regard to effects of noradrenaline, theophylline, prostaglandin E1 and age. Acta Chir Scand (1969) 0.78
Underexpression of the apolipoprotein E4 isoform in an Italian population. Arterioscler Thromb (1993) 0.77
Apoprotein D in a healthy, male population and in male myocardial infarction patients and their male, first-degree relatives. Atherosclerosis (1986) 0.77
Interrelationships of microangiopathy, plasma glucose and other risk factors in 3583 diabetic patients: a multinational study. Diabetologia (1982) 0.77
Amino acids and lipoproteins in plasma of duodenopancreatectomized patients: effects of glucagon in physiological amounts. Eur J Clin Invest (1983) 0.77
HDL and coronary heart disease: a familial trend. Adv Exp Med Biol (1987) 0.77
Factors influencing the low density lipoprotein profile in type 2 diabetic patients. Diabet Med (1995) 0.77
Acquired (secondary) forms of hypertriglyceridemia. Am J Cardiol (1991) 0.77
Decreased HDL cholesterol in prepubertal and pubertal children of CHD patients. Atherosclerosis (1980) 0.76
Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies. Diabetologia (1993) 0.76
HDL cholesterol levels in patients with myocardial infarction and their families. Atherosclerosis (1986) 0.76
Quantitative estimates of the evolution of a malaria epidemic in Turkey if remedial measures had not been applied. Bull World Health Organ (1980) 0.76
[Sero-epidemiological study on the endemic occurrence of treponema infections in Senegal]. Bull World Health Organ (1979) 0.75
Dynamics of acute bacterial diseases. Epidemiological models and their application in public health. Part I. Theory and practice of epidemiological models. Bull World Health Organ (1978) 0.75
Commentary on "Embracing complexity: A consideration of hypertension in the very old". J Gerontol A Biol Sci Med Sci (2003) 0.75
The international reference preparation of colistin methane sulfonate. Bull World Health Organ (1973) 0.75
Marked changes of lipid levels during puberty in a patient with lipoprotein lipase deficiency. Eur J Pediatr (1997) 0.75
The second international standard for polymyxin B. Bull World Health Organ (1973) 0.75
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level. Am J Ophthalmol (1994) 0.75
Comparative epidemiological analysis of sanitation and immunization in the control of typhoid and cholera. Am J Public Health (1974) 0.75
The second International Standard for Dihydrostreptomycin. Bull World Health Organ (1966) 0.75
[A study of the heat stability of 8 samples of yellow fever vaccine coming from various countries]. Bull World Health Organ (1971) 0.75
The second International Standard for Oxytetracycline. Bull World Health Organ (1967) 0.75
[Plasma lipoproteins. Influence of heredity and external factors in the genesis of dyslipidemias]. Rev Med Suisse Romande (1980) 0.75
Epitope expression in purified and lipid-bound forms of human apoprotein A-I. Adv Exp Med Biol (1987) 0.75
[Drug therapy of hyperlipoproteinemias]. Ther Umsch (1980) 0.75
[Dyslipidemias and atherosclerosis. Treatment strategy]. Schweiz Rundsch Med Prax (1986) 0.75
Interference of dimethyl alpha-(dimethoxyphosphinyl) p-chlorobenzyl phosphate (SR-202) in thyroid hormone metabolism: evidence of inhibition of monodeiodination. J Endocrinol (1987) 0.75
[Teaching and Treatment Unit in the Division of Diabetology (Geneva)]. Rev Med Suisse Romande (1980) 0.75
[Lipoprotein metabolism and atherosclerosis]. Schweiz Rundsch Med Prax (1988) 0.75
High density lipoprotein (HDL) subfractions in cardiovascular patients with low levels of HDL-cholesterol. Influence of hypertriglyceridaemia on subfraction concentration and composition. Atherosclerosis (1988) 0.75
[Dietary treatment of the hyperlipidemias]. Ther Umsch (1986) 0.75